Veradigm | MDRX - SCHULD





SCHULD Veränderung Datum
Alcidion AUD 1.37M 329K 2024-12
Ambu A/S DKK 551M 6M 2026-03
Amplifon EUR 1.79B 31.89M 2026-03
Cardinal Health USD 8.89B 30M 2026-06
Centene USD 16.1B 266M 2026-06
Charles River Laboratories USD 3.06B 485.84M 2026-03
Cigna USD 30.9B 563M 2026-03
Coloplast 18.67B 35M 2023-09
Convatec Group USD 1.2B 210.3M 2024-12
CVS Health USD 61.41B 16.94B 2026-06
Diasorin EUR 769.18M 97.18M 2025-06
Elevance Health USD 31.04B 798M 2026-06
General Electric Aerospace USD 19.16B 1.12B 2026-06
Gulf Medical Proj AED 7.67M 1.75M 2025-03
Humana USD 14.25B 254M 2026-06
IQVIA Holdings USD 16.24B 408M 2026-06
Laboratory Of America USD 7.24B 714.6M 2026-03
Maximus USD 1.63B 42.48M 2026-03
McKesson USD 8.61B 10M 2026-03
Med Life RON 2.02B 74.6M 2026-03
Molina Healthcare USD 3.95B 3M 2026-03
Omnicell USD 202.18M 2.16M 2026-03
Oriola-kd EUR 76.1M 13M 2024-12
Owens Minor USD 1.95B 91.18M 2025-03
Quest Diagnostics USD 6.41B 179M 2026-03
Rede D'or Sao Luiz BRL 52.46B 2.5B 2026-03
Siemens Healthineers EUR 821M 57M 2026-03
Sonova Holding CHF 1.91B 130.9M 2023-06
Supermax Corporation Bhd MYR 163.09M 1.07M 2026-03
UnitedHealth USD 73.33B 4.59B 2026-06
Veeva Systems USD 95.86M 6.06M 2025-12
Veradigm USD 200.33M 431K 2022-09
Xerox USD 3.3B 101M 2025-03